Aarkstore.com announces, The Latest market research report is available inits vast collection:M et P Pharma AG – Product Pipeline Review – 2012http://www.aarkstore.com/reports/M-et-P-Pharma-AG-Product-Pipeline-Review-2012-217894.htmlRSS link of Global Markets Directhttp://www.aarkstore.com/feeds/Global-Markets-Direct.xmlSummaryGlobal Market Direct’s pharmaceuticals report, “M et P Pharma AG - ProductPipeline Review - 2012” provides data on the M et P Pharma AG’s research anddevelopment focus. The report includes information on current developmentalpipeline, complete with latest updates, and features on discontinued and dormantprojects.This report is built using data and information sourced from Global Markets Direct’sproprietary databases, M et P Pharma AG’s corporate website, SEC filings, investorpresentations and featured press releases, both from M et P Pharma AG andindustry-specific third party sources, put together by Global Markets Direct’s team.Scope- M et P Pharma AG - Brief M et P Pharma AG overview including businessdescription, key information and facts, and its locations and subsidiaries.- Review of current pipeline of M et P Pharma AG human therapeutic division.- Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development,including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of M et P Pharma AG withcomplete description of the product’s developmental history, mechanism of action,therapeutic class, target and major milestones.Table of contents:List of Tables 3List of Figures 3M et P Pharma AG Snapshot 4M et P Pharma AG Overview 4Key Information 4Key Facts 4M et P Pharma AG – Research and Development Overview 5Key Therapeutic Areas 5M et P Pharma AG – Pipeline Review 7Pipeline Products by Stage of Development 7Pipeline Products – Monotherapy 8M et P Pharma AG – Pipeline Products Glance 9M et P Pharma AG Clinical Stage Pipeline Products 9Phase II Products/Combination Treatment Modalities 9Phase I Products/Combination Treatment Modalities 10M et P Pharma AG – Early Stage Pipeline Products 11Pre-Clinical Products/Combination Treatment Modalities 11M et P Pharma AG – Drug Profiles 12DopaMat 12Product Description 12Mechanism of Action 12R&D Progress 12Nasobol 13Product Description 13Mechanism of Action 13R&D Progress 13Noseafix 14Product Description 14Mechanism of Action 14R&D Progress 14PregnenoMat 15
Product Description 15Mechanism of Action 15R&D Progress 15ProgestoMat 16Product Description 16Mechanism of Action 16List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Product Pipeline Review – 2012http://www.aarkstore.com/search/viewresults.asp?search=Product PipelineReview&PubId=&pagenum=1Infinity Pharmaceuticals, Inc. – Product Pipeline Review – 2012Intarcia Therapeutics, Inc. – Product Pipeline Review – 2012InterMed Discovery GmbH – Product Pipeline Review – 2012Jenrin Discovery, Inc. – Product Pipeline Review – 2012M et P Pharma AG – Product Pipeline Review – 2012Fresenius Biotech GmbH – Product Pipeline Review – 2012Evolva SA – Product Pipeline Review – 2012Glycotope GmbH – Product Pipeline Review – 2012
Hawthorn Pharmaceuticals, Inc. – Product Pipeline Review – 2012Helsinn Healthcare S.A. – Product Pipeline Review – 2012Hygeia Therapeutics, Inc. – Product Pipeline Review – 2012IkerChem S.L. – Product Pipeline Review – 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcarehttp://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals andHealthcare&PubId=&pagenum=1You can also request for sample page of above mention reports email@example.comFor More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: firstname.lastname@example.org